Nanoparticles: Novel Vehicles in Treatment of Glioblastoma

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Nanoparticles: Novel Vehicles in Treatment of Glioblastoma Publisher Pubmed

Pourgholi F^{1, 2, 3} ; Hajivalili M^{1, 2, 3} ; Farhad JN⁴ ; Kafil HS³ ; Yousefi M^{2, 3}

Source: Biomedicine and Pharmacotherapy Published:2016

Abstract

Glioblastoma multiform (GBM) is the most common brain tumor. The current GBM treatments comprise of radiation therapy, chemotherapy and surgery. One of the most important problems regarding the treatment of GBM is the presence of blood brain barrier (BBB) which inhibits the efficient drug delivery into central nervous system (CNS). Nanothechnology can help to deliver therapeutic drugs into CNS through crossing the BBB. There are different types of nanoparticles (Nps) which can be manipulated for clinical applications as a treatment for CNS-related disorders. In this review, we will discuss the role of Nps in the treatment of GBM. © 2015.

Related Docs

View other Related Docs

1. The Use of Nanoparticles As a Promising Therapeutic Approach in Cancer Immunotherapy, Artificial Cells# Nanomedicine and Biotechnology (2016)

2. Nano-Structures Mediated Co-Delivery of Therapeutic Agents for Glioblastoma Treatment: A Review, Materials Science and Engineering C (2016)

3. Application of Nanomedicine for Crossing the Blood–Brain Barrier: Theranostic Opportunities in Multiple Sclerosis, Journal of Immunotoxicology (2016)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (2)

Mahdi Adabi (2)

Other Related Docs

4. Polymeric Nanoparticles for Drug Delivery in Glioblastoma: State of the Art and Future Perspectives, Journal of Controlled Release (2022)

5. Nanobased Cns Delivery Systems, Nanobiomaterials: Applications in Drug Delivery (2018)

6. A Concise Review on Cancer Treatment Methods and Delivery Systems, Journal of Drug Delivery Science and Technology (2019)

7. Immunoengineering in Glioblastoma Imaging and Therapy, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (2019)

8. Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms, Vaccines (2022)

9. Local Delivery of Ibrutinib by Folate Receptor-Mediated Targeting Plga–Peg Nanoparticles to Glioblastoma Multiform: In Vitro and in Vivo Studies, Journal of Drug Targeting (2025)

10. Angioregulatory Role of Mirnas and Exosomal Mirnas in Glioblastoma Pathogenesis, Biomedicine and Pharmacotherapy (2022)

11. A Review of Chitosan-Based Nanocarriers As Drug Delivery Systems for Brain Diseases: Critical Challenges, Outlooks and Promises, International Journal of Biological Macromolecules (2024)

12. In Vitro Models and Systems for Evaluating the Dynamics of Drug Delivery to the Healthy and Diseased Brain, Journal of Controlled Release (2018)

13. Engineered Solid Lipid Nanoparticles and Nanostructured Lipid Carriers As New Generations of Blood-Brain Barrier Transmitters, ACS Chemical Neuroscience (2021)

14. Synthesis and Characterization of a Pamam Dendrimer Nanocarrier Functionalized by Srl Peptide for Targeted Gene Delivery to the Brain, European Journal of Pharmaceutical Sciences (2015)

15. The Role of Cell Membrane-Coated Nanoparticles As a Novel Treatment Approach in Glioblastoma, Frontiers in Molecular Biosciences (2023)

16. Targeting Neuroinflammation by Intranasal Delivery of Nanoparticles in Neurological Diseases: A Comprehensive Review, Naunyn-Schmiedeberg's Archives of Pharmacology (2022)

17. Inorganic Nanoparticles-Based Drug Delivery Systems for Neurodegenerative Diseases Therapy, Current Pharmaceutical Design (2025)

18. The Role of Celecoxib in Glioblastoma Treatment: A Review of Literature, World Cancer Research Journal (2020)

19. Nanocarriers in Glioblastoma Treatment: A Neuroimmunological Perspective, Reviews in the Neurosciences (2024)

20. Nanoparticles in Cancer Theranostics: Focus on Gliomas, BioNanoScience (2025)

Style	Citing Format
MLA	Pourgholi F, et al.. "Nanoparticles: Novel Vehicles in Treatment of Glioblastoma." Biomedicine and Pharmacotherapy, vol. 77, no. , 2016, pp. 98-107.
APA	Pourgholi F, Hajivalili M, Farhad JN, Kafil HS, Yousefi M (2016). Nanoparticles: Novel Vehicles in Treatment of Glioblastoma. Biomedicine and Pharmacotherapy, 77(), 98-107.
Chicago	Pourgholi F, Hajivalili M, Farhad JN, Kafil HS, Yousefi M. "Nanoparticles: Novel Vehicles in Treatment of Glioblastoma." Biomedicine and Pharmacotherapy 77, no. (2016): 98-107.
Harvard	Pourgholi F et al. (2016) 'Nanoparticles: Novel Vehicles in Treatment of Glioblastoma', Biomedicine and Pharmacotherapy, 77(), pp. 98-107.
Vancouver	Pourgholi F, Hajivalili M, Farhad JN, Kafil HS, Yousefi M. Nanoparticles: Novel Vehicles in Treatment of Glioblastoma. Biomedicine and Pharmacotherapy. 2016;77():98-107.
BibTex	@article{ author = {Pourgholi F and Hajivalili M and Farhad JN and Kafil HS and Yousefi M}, title = {Nanoparticles: Novel Vehicles in Treatment of Glioblastoma}, journal = {Biomedicine and Pharmacotherapy}, volume = {77}, number = {}, pages = {98-107}, year = {2016} }
RIS	TY - JOUR AU - Pourgholi F AU - Hajivalili M AU - Farhad JN AU - Kafil HS AU - Yousefi M TI - Nanoparticles: Novel Vehicles in Treatment of Glioblastoma JO - Biomedicine and Pharmacotherapy VL - 77 IS - SP - 98 EP - 107 PY - 2016 ER -

Science Communicator Platform

Authors

Abstract